Divergent Effects of Cyclophilin-D Inhibition on the Female Rat Heart: Acute Versus Chronic Post-Myocardial Infarction

Cell Physiol Biochem. 2018;50(1):288-303. doi: 10.1159/000494006. Epub 2018 Oct 3.

Abstract

Background/aims: The mitochondrial permeability transition pore opening plays a critical role in the pathogenesis of myocardial infarction. Inhibition of cyclophilin-D (CyP-D), a key regulator of the mitochondrial permeability transition pore, has been shown to exert cardioprotective effects against ischemia-reperfusion injury on various animal models, mostly in males. However, failure of recent clinical trials requires a detailed elucidation of the cardioprotective efficacy of CyP-D inhibition. The aim of this study was to examine whether cardioprotective effects of sanglifehrin A, a potent inhibitor of CyP-D, on post-infarcted hearts depends on reperfusion.

Methods: Acute or chronic myocardial infarction was induced by coronary artery ligation with/without subsequent reperfusion for 2 and 28 days in female Sprague-Dawley rats. Cardiac function was estimated by echocardiography. Oxygen consumption rates, ROS production, permeability transition pore opening, protein carbonylation and respiratory supercomplexes were analyzed in isolated cardiac mitochondria.

Results: Sanglifehrin A significantly improved cardiac function of reperfused hearts at 2 days but failed to protect after 28 days. No protection was observed in non-reperfused post-infarcted hearts. The respiratory control index of mitochondria was significantly reduced in reperfused infarcted hearts at 2-days with no effect at 28-days post-infarction on reperfused and non-reperfused hearts. Likewise, only a minor increase in reactive oxygen species production was observed at 2-days in non-reperfused post-infarcted hearts.

Conclusion: This study demonstrates that CyP-D inhibition exerts cardioprotective effects in reperfused but not in non-reperfused infarcted hearts of female rats, and the effects are observed only during acute post-infarction injury.

Keywords: Cardioprotection; Cyclophilin D; Mitochondrial permeability transition; Myocardial infarction; Reperfusion; Sanglifehrin A.

MeSH terms

  • Acetylation
  • Acute Disease
  • Animals
  • Chronic Disease
  • Cyclophilins / antagonists & inhibitors*
  • Cyclophilins / metabolism
  • Echocardiography
  • Female
  • Heart / drug effects*
  • Lactones / pharmacology
  • Mitochondria, Heart / metabolism
  • Mitochondrial Membrane Transport Proteins / metabolism
  • Mitochondrial Permeability Transition Pore
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / pathology*
  • Myocardial Infarction / veterinary
  • Oxygen Consumption / drug effects
  • Peptidyl-Prolyl Isomerase F
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Sirtuins / metabolism
  • Spiro Compounds / pharmacology

Substances

  • Peptidyl-Prolyl Isomerase F
  • Lactones
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Reactive Oxygen Species
  • SIRT3 protein, rat
  • Spiro Compounds
  • sanglifehrin A
  • Sirtuins
  • Cyclophilins